Oral Treatment of Spontaneously Hypertensive Rats with Captopril-Surface Functionalized Furosemide-Loaded Multi-Wall Lipid-Core Nanocapsules
Multi-wall lipid-core nanocapsule (MLNC) functionalized with captopril and nanoencapsulating furosemide within the core was developed as a liquid formulation for oral administration. The nanocapsules had mean particle size below 200 nm, showing unimodal and narrow size distributions with moderate di...
Main Authors: | Cecilia B. Michalowski, Marcelo D. Arbo, Louise Altknecht, Andréia N. Anciuti, Angélica S. G. Abreu, Luciana M. R. Alencar, Adriana R. Pohlmann, Solange C. Garcia, Sílvia S. Guterres |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/1/80 |
Similar Items
-
POTASSIUM MONITORING IN HEART FAILURE PATIENTS RECEIVING COMBINED THERAPY OF CAPTOPRIL AND FUROSEMIDE
by: Hubby Hubby, et al.
Published: (2017-08-01) -
Development of nanocapsule suspensions and nanocapsule spray-dried powders containing melatonin
by: Schaffazick Scheila R., et al.
Published: (2006-01-01) -
Development and physicochemical characterization of dexamethasone-loaded polymeric nanocapsule suspensions
by: Rossana Barcellos Friedrich, et al.
Published: (2008-01-01) -
POSSIBILITIES OF PROLONGED BLOOD PRESSURE MONITORING IN ASSESSMENT OF THE EFFICACY AND SAFETY OF COMBINED ANTIHYPERTENSIVE THERAPY IN EMERGENCY CARE
by: V. V. Ruksin, et al.
Published: (2022-04-01) -
Furosemide in Hypovolemic shock
by: Khalid Ali Khaleel
Published: (2020-12-01)